Recombinant LCAT ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
259レシチンコレステロールアシルトランスフェラーゼ欠損症1

259. レシチンコレステロールアシルトランスフェラーゼ欠損症


臨床試験数 : 1 薬物数 : 1 - (DrugBank : 0) / 標的遺伝子数 : 0 - 標的パスウェイ数 : 0
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04737720
(ClinicalTrials.gov)
January 24, 20133/2/2021Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)Analysis of Samples Collected From a Subject Who Received ACP- 501 (Human Recombinant Lecithin:Cholesterol Acyltransferase [rhLCAT])Familial LCAT DeficiencyDrug: Recombinant LCATNational Heart, Lung, and Blood Institute (NHLBI)NULLCompleted18 Years100 YearsAll1United States